Unger EF, et al. Erythropoiesis-stimulating agents: Time for a reevaluation. N Engl J Med 2010; 362:189–192.
Lin FK, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 82:7580–7584.
Szczech LA, et al. Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 2008; 74:791–798.
Haase VH. Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies. Exp Cell Res 2017; 356:160–165.
Fishbane S, Frei GL, Maesaka J. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 1995; 26:41–46.
Macdougall IC, et al. Intravenous iron in patients undergoing maintenance hemodialysis. N Engl J Med 2019; 380:447–458.
Anker SD, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009; 361:2436–2448.
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory